Lilly India gets nod for restricted EU of monoclonal antibody drugs, bamlanivimab and etesevimab to…
Bamlanivimab and etesevimab together have been authorised under Emergency Use Authorization in the US and select EU countries, for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
bamlanivimab
Lilly’s bamlanivimab plus etesevimab cut death, hospitalisations for early COVID-19 in Phase…
Results support use of bamlanivimab 700 mg and etesevimab 1400 mg, the dose authorised in the US and several other countries
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19
Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…
Scientists find five key genes are linked to severe COVID-19
The genes - called IFNAR2, TYK2, OAS1, DPP9 and CCR2 – partially explain why some people become desperately sick with COVID-19
US to begin distribution of Bamlanivimab, COVID-19 antibody from Eli Lilly
Bamlanivimab allocations to states and territories will be based on their number of hospitalised COVID-19 patients and the number…
AbCellera antibody gets US FDA EUA as monotherapy for COVID-19 treatment
AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to…